本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

12.52
-0.1800-1.42%
盤後12.520.00000.00%16:10 EDT
成交量:27.77萬
成交額:350.22萬
市值:3.63億
市盈率:-5.35
高:12.84
開:12.67
低:12.49
收:12.70
52周最高:17.15
52周最低:7.05
股本:2,901.85萬
流通股本:2,251.30萬
量比:0.97
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-2.3416
每股收益(LYR):-3.8381
淨資產收益率:-70.12%
總資產收益率:-12.28%
市淨率:3.59
市盈率(LYR):-3.26

資料載入中...

2022/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

重要事件披露

8-K - Current report
2022/03/08

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

重要事件披露

8-K - Current report
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities